AbstractHuman adenovirus serotype 5 (HAdV-5) attaches to its primary receptor, the coxsackie and adenovirus receptor (CAR) as the first step of infection. However, CAR expression decreases as tumors progress, thereby diminishing the utility of HAdV-5-based vectors for cancer therapy. In contrast, many aggressive tumor cells highly express CD46, a cellular receptor for HAdV-3. We hypothesized that a mosaic HAdV vector, containing two kinds of fiber proteins, would provide extensive transduction in a heterogeneous population of tumor cells with varying expression levels of HAdV receptors. We therefore generated a fiber-mosaic HAdV vector displaying both a chimeric HAdV-3 fiber and the HAdV-5 fiber protein. We verified the structural integrity...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
AbstractHuman adenovirus serotype 5 (HAdV-5) attaches to its primary receptor, the coxsackie and ade...
AbstractMost adenoviral vectors use in gene therapy protocols derive from species C. However, expres...
AbstractThe efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
<div><p>Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene t...
Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene therapy, ...
AbstractMost adenoviral vectors use in gene therapy protocols derive from species C. However, expres...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
AbstractHuman adenovirus serotype 5 (HAdV-5) attaches to its primary receptor, the coxsackie and ade...
AbstractMost adenoviral vectors use in gene therapy protocols derive from species C. However, expres...
AbstractThe efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
The human adenovirus (HAdV) phylogenetic tree is diverse, divided across seven species and comprisin...
<div><p>Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene t...
Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene therapy, ...
AbstractMost adenoviral vectors use in gene therapy protocols derive from species C. However, expres...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...
The efficiency of cancer gene therapy with recombinant adenoviruses based on serotype 5 (Ad5) has be...